Healthcare, Consumer Staples Mar 14, 2022 08:59 PM (GMT+8) · EqualOcean
Dongyangguang announced that previously, the controlling shareholder of the company issued a commitment to give the company the right to purchase the corresponding equity of Guangdong dongyangguang Pharmaceutical Co., Ltd. (hereinafter referred to as "Guangyao") from it and / or its designated third party in the future. Accordingly, the company intends to exercise the relevant rights to purchase the registered capital of Guangyao 14.2513 million yuan (hereinafter referred to as the "subject equity") held by Shenzhen dongyangguang industry with 910 million yuan, accounting for 5.0966% of the equity of Guangyao.